Opko Health (OPK) Restructuring Costs (2012 - 2013)

Opko Health (OPK) reported Restructuring Costs of $2.6 million for Q2 2013, up 167.05% on a YoY basis from $965000.0 in Q2 2012, and up 91.74% quarter-over-quarter from $1.3 million in Q1 2013.

Opko Health (OPK) Restructuring Costs (2012 - 2013) Analysis & Trends

Opko Health has reported Restructuring Costs for 2 years, with the latest figure at $2.6 million in Q2 2013.

  • For the quarter ending Q2 2013, Restructuring Costs rose 167.05% year-over-year to $2.6 million; the trailing twelve-month figure through Jun 2013 stood at $2.6 million (changed N/A YoY), and the FY2012 full-year result was $785000.0, changed N/A from the prior year.
  • Restructuring Costs for Q2 2013 stood at $2.6 million, up from $1.3 million in the prior quarter.
  • The five-year high for Restructuring Costs was $2.6 million in Q2 2013, with the low at -$1.9 million in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn
10 Opko Health 1.09 Bn 747.11 Mn 45.76 Mn

Historic Data

Download Data
DateValue
Jun 30, 2013 2.58 Mn
Mar 31, 2013 1.34 Mn
Dec 31, 2012 -1.88 Mn
Sep 30, 2012 556,000.00
Jun 30, 2012 965,000.00
Mar 31, 2012 1.14 Mn